College of Chemistry, Sichuan University, Chengdu, 610064, P. R. China.
Analyst. 2020 Mar 21;145(6):2219-2225. doi: 10.1039/c9an02340b. Epub 2020 Feb 18.
An enzyme-free and label-free visual sensing strategy was developed for sensitively detecting thrombin using a plasmonic nanoplatform. Both the thrombin-triggered catalytic hairpin assembly (CHA) amplification reaction and G-quadruplex/hemin DNAzyme-controlled plasmonic signal readout were engineered on an electrospun nanofibrous membrane. Owing to its large specific surface area and porous structure, the nanofibrous membrane enhanced the loading capacity of B-H2 and the interface interaction efficiency. This plasmonic nanoplatform was used to perform the sensitive and naked-eye detection of thrombin as low as 1.0 pM in human serum samples. This visual strategy can discriminate thrombin from other co-existing proteins very well. Moreover, the visual sensing platform exhibited excellent reusability and long-term stability. The proposed enzyme-free and label-free plasmonic nanoplatform is low-cost, easy to operate and highly sensitive, and has potential applications in the point-of-care detection of protein biomarkers.
开发了一种无酶和无标记的可视化传感策略,用于使用等离子纳米平台灵敏地检测凝血酶。在静电纺纳米纤维膜上设计了凝血酶触发的催化发夹组装 (CHA) 扩增反应和 G-四链体/血红素 DNA 酶控制的等离子体信号读出。由于其大的比表面积和多孔结构,纳米纤维膜增强了 B-H2 的负载能力和界面相互作用效率。该等离子体纳米平台用于在人血清样本中以低至 1.0 pM 的浓度灵敏且无需肉眼检测凝血酶。这种可视化策略可以很好地区分凝血酶与其他共存蛋白质。此外,该可视化传感平台表现出良好的可重复使用性和长期稳定性。该无酶和无标记的等离子体纳米平台成本低、操作简单、灵敏度高,在蛋白质生物标志物的即时检测中具有潜在的应用。